Table 1.
Characteristics of the study participants.
| Sex | Age Group | COVID-19 Infections from March to May 2022 N = 245,803 |
No. of People with COVID-19 Sampled N = 3361 |
No. of People with COVID-19 Who Responded N = 1981 |
Response Rate (%) |
|---|---|---|---|---|---|
| Male | 0–9 | 4453 (1.81%) | 53 (1.58%) | 40 (2.02%) | 65.57 |
| 10–19 | 5653 (2.3%) | 76 (2.26%) | 38 (1.92%) | 49.35 | |
| 20–29 | 22,151 (9.01%) | 333 (9.91%) | 153 (7.72%) | 50.50 | |
| 30–39 | 30,411 (12.37%) | 405 (12.05%) | 238 (12.01%) | 57.21 | |
| 40–49 | 24,528 (9.98%) | 365 (10.86%) | 199 (10.05%) | 59.40 | |
| 50–59 | 28,536 (11.61%) | 376 (11.19%) | 229 (11.56%) | 58.72 | |
| 60–69 | 14,337 (5.83%) | 189 (5.62%) | 106 (5.35%) | 54.08 | |
| 70–79 | 7038 (2.86%) | 96 (2.86%) | 59 (2.98%) | 61.46 | |
| 80+ | 3310 (1.35%) | 55 (1.64%) | 34 (1.72%) | 75.56 | |
| Female | 0–9 | 3826 (1.56%) | 49 (1.46%) | 33 (1.67%) | 63.46 |
| 10–19 | 3946 (1.61%) | 53 (1.58%) | 29 (1.46%) | 53.70 | |
| 20–29 | 12,485 (5.08%) | 182 (5.42%) | 95 (4.80%) | 55.56 | |
| 30–39 | 20,122 (8.19%) | 244 (7.26%) | 175 (8.83%) | 63.64 | |
| 40–49 | 18,182 (7.4%) | 232 (6.90%) | 165 (8.33%) | 66.27 | |
| 50–59 | 20,647 (8.4%) | 300 (8.93%) | 174 (8.78%) | 61.70 | |
| 60–69 | 13,721 (5.58%) | 170 (5.06%) | 113 (5.70%) | 60.11 | |
| 70–79 | 7245 (2.95%) | 103 (3.06%) | 60 (3.03%) | 60.61 | |
| 80+ | 5212 (2.12%) | 80 (2.38%) | 41 (2.07%) | 57.75 |